Taiwan FDA registration 9d90eb52f92373fea49ef68ead823c9a
"KuaiAn" reverse transcription nucleic acid amplification test set (unsterilized)
TW: "快安" 反轉錄核酸放大試藥組 (未滅菌)
Taiwan·Risk Class 1·QIAGEN GMBH·Registered Oct 03, 2011 – Oct 03, 2016CancelledRegistration details
- Analysis ID
- 9d90eb52f92373fea49ef68ead823c9a
- Customs Code
- DHA04401088908
Company information
- Manufacturer
- QIAGEN GMBH
- Manufacturer Country
- Germany
- Authorized Representative
- TAIGEN BIOSCIENCE CORPORATION
Product details
- Intended Use
- Limited to the first level identification scope of "General Purpose Reaction Reagents (B.4010)" under the Measures for the Administration of Medical Devices.
- Product Type (Level 1)
- B Hematology, pathology, and genetics
- Product Type (Level 2)
- B.4010 Reaction Reagents for General Purposes
- Import Information
- import
Dates and status
- Registration Date
- Oct 03, 2011
- Expiry Date
- Oct 03, 2016
- Cancellation Date
- Jun 26, 2018
Cancellation information
- Status
- Logged out
- Reason
- 許可證已逾有效期
About this record
Access comprehensive regulatory information for "KuaiAn" reverse transcription nucleic acid amplification test set (unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 9d90eb52f92373fea49ef68ead823c9a and manufactured by QIAGEN GMBH. The authorized representative in Taiwan is TAIGEN BIOSCIENCE CORPORATION.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices